Rianne Oostenbrink

Rianne Oostenbrink is a researcher in the Department of Pediatrics at Erasmus MC, with a strong focus on neurofibromatosis type 1 (NF1), pediatric oncology, and emergency care. Her work spans clinical research, observational studies, and multicenter collaborations, contributing significantly to the understanding and management of rare pediatric conditions.

Her research interests center on Neurofibromatosis Type 1, particularly cognitive deficits, optic pathway gliomas, and long-term outcomes. She also investigates emergency department utilization in pediatric chronic diseases and the feasibility of clinical guidelines in real-world settings. Her work often involves large-scale data analysis, electronic health records, and national cohort studies.

The recent publications reflect a consistent trend in pediatric neuro-oncology and genetic disorders, with emphasis on clinical trials (e.g., lamotrigine for cognition), risk prediction models, and healthcare implementation. Her studies frequently employ observational and retrospective designs, leveraging multicenter datasets to improve diagnosis, treatment, and quality of life for children with NF1.

She is actively involved in the ENCORE Expertise Center for NF1 and collaborates with national and international consortia such as PESUDY and COPP-IGAS. Her research has been cited across platforms including Scopus, Mendeley, and social media, indicating broad academic engagement.

Rianne Oostenbrink has supervised at least six academic works, reflecting her role in mentoring junior researchers and contributing to academic training in pediatric research. She has not received any explicitly mentioned scientific awards in the provided text.

Her laboratory and team affiliations include the ENCORE Expertise Center for NF1 and participation in nationwide pediatric research networks, enabling large-scale, impactful studies in rare diseases.